Health·Second Opinion

Controversial U.S. stem cell clinics have Canadian connections

The U.S. Food and Drug Administration moved this week to shut down several clinics offering unapproved stem cell therapies, including one network with three affiliates in Canada.

The FDA is seeking an injunction to stop U.S.-based network from using unapproved stem cell treatments

Dr. Mark Berman, of the Cell Surgical Network, injects a patient with a solution he says is rich in adult stem cells at his practice in Beverly Hills, Calif., in this December 2014 file photo. (Raquel Maria Dillon/Associated Press)

This is an excerpt from Second Opinion, a weekly roundup of eclectic and under-the-radar health and medical science news emailed to subscribers every Saturday morning. 

If you haven't subscribed yet, you can do that by clicking here.


The U.S. Food and Drug Administration (FDA) moved this week to shut down several clinics in the U.S. offering unapproved stem cell therapies, including one network that has affiliated clinics in Canada.

The California-based Cell Surgical Network is facing a U.S. Department of Justice application for a permanent injunction to prevent the clinics "from experimenting on patients with adulterated and misbranded drugs," according to a legal document filed with a U.S. District Court in California.

Cell Surgical Network (CSN) confirmed to CBC News in an email that it has three affiliated clinics in Canada that also perform stem cell procedures — one in Vancouver, one in Kamloops B.C., and one in Sudbury, Ont.

Dr. Martin Braun is the president and owner of the Vancouver Stem Cell Treatment Centre. (Vancouver Stem Cell Treatment Centre)

Dr. Martin Braun, a former emergency physician who specializes in botox injections, runs the Vancouver clinic. He told CBC News his clinic has performed the stem cell procedures on 200 Canadian patients since 2015, treating multiple sclerosis, emphysema, asthma, and chronic back and joint pain.

There is no fee to be part of the Cell Surgical Network, he said, but affiliated clinics are required to buy CSN equipment and follow CSN protocol to remove fat tissue and process it before re-injecting it either directly or intravenously into the same patient.

The procedures cost between $5,000 and $8,000 and Canadian patients are entered into the wider CNS database, Braun said. Patients are also required to sign the network's consent form, which tells them they are part of a research study.

"We tell people this is patient-funded medical research," Braun said. "We're not making any claims, warranties or assurances on anything."

He said he has not told Health Canada he is doing the procedures.

"I didn't alert them that I'm doing it," he said. "I get very upset when the government — certainly the federal government — interferes with the patient-physician relationship."

Health Canada is reviewing Canadian affiliates

Health Canada told CBC News in an email that it is reviewing the situation.

"Health Canada is following up with regard to the Canadian clinics that you have identified," wrote spokesperson Anna Maddison. "Should the department identify any non-compliance with the Food and Drugs Act and associated regulations, it will take appropriate action."

Last November, Health Canada also said it was investigating after CBC News reported on a series of private clinics that were performing unapproved stem cell procedures.

Dr. Mark Berman collects fat from a patient's back as the part of a stem cell procedure in Beverly Hills, Calif., in this December 2014 file photo. (Raquel Dillion/Associated Press)

The Cell Surgical Network was established in 2012 by Elliot Lander, a urologist, and Mark Berman, a cosmetic surgeon. It has since expanded to include 100 clinics across the United States and international clinics in Europe, New Zealand, China and Iran, as well as the three Canadian affiliates.

According to the court document, affiliates of the network are required to follow "instructions and treatment procedures," which involve extracting fat tissue from patients' buttocks and abdomen and processing it through a series of steps, before re-injecting it either directly or intravenously into specific parts of the body, including the brain and spinal cord.

Stem cells are 'drugs'

The FDA maintains that stem cells extracted from fat tissue are "drugs" and must be formally tested and approved. The agency had already warned the clinics last year that they were operating outside FDA rules.

"There have been no adequate and well-controlled studies performed on the [company's] products demonstrating that they are safe or effective for any indication," the court document state.

"That's why these businesses are basically being taken to court by the FDA," said Leigh Turner, a bioethicist at University of Minnesota who has been tracking the evolution of private stem cell clinics.

"They were flaunting federal law, they had multiple chances to stop, they refused to stop and so the FDA is now seeking a permanent injunction."

Leigh Turner is a bioethicist and an associate professor at the University of Minnesota. (University of Nebraska)

Braun, from the Vancouver clinic, argues the cells he is injecting into patients are not drugs, but simply the patient's own cells used in a new way.

He said he decided to start offering the stem cell procedures at his private Vancouver laser and skin care clinic because he'd tried it himself. In 2014, he travelled to California to have the stem cell treatment on his knees after a skiing accident. He's now had the procedure twice.

"The naysayers call it placebo effect," he said.

This is a regulatory space where they've been vague and very fuzzy. And businesses flock to gaps like that.- Leigh Turner, bioethicist

Health Canada hasn't approved any stem cell therapies for pain, chronic disease, or neurological or cardiac disorders. So far only one therapy has been approved to treat complications from a childhood cancer treatment.

"Health Canada authorization is required before any cell therapy can be legally used on human patients," Health Canada wrote in the email. "Manufacturers and researchers are required to submit scientific evidence to support the use of these therapies."

FDA found records of patient harms: document

The court document state FDA inspectors found records that document adverse patient reactions, including infections, loss of consciousness and hospitalization.

Braun said he has not had any adverse reactions at his clinic.

The Nardella Clinic in Calgary also has a relationship with CSN but it is not an official affiliate and says it doesn't conduct stem cell treatments. But practitioners at the naturopathic clinic sometimes refer patients to the California clinics run by Lander and Berman.

"A lot of patients come with stem cell questions because they know about them — they Google it," said Ed Trahan, Nardella's business manager. "If they were interested, [our naturopaths] would put them in contact with a clinic."

When asked if Nardella will still be referring patients to CNS after the FDA's move to shut down the clinics, Trahan said he didn't know. "We have to figure out what's going on."

The FDA maintains that stem cells extracted from fat tissue are 'drugs' and must be formally tested and approved. (Associated Press)

CBC News reached out to the other two Canadian affiliates — Welcome Back Regenerative Medicine Centre in Kamloops and the Ontario Stem Cell Treatment Centre in Sudbury — but did not receive a response.

Both are identified by CSN as being affiliated with the U.S. network.

In a statement to CBC News, CSN said it intended to "vigorously defend" itself against the FDA action.

"CSN strongly rejects the idea that a person's own cells should be regulated by the FDA as a drug," said the statement.

According to Turner, a lack of clear direction from regulators like Health Canada is creating a vacuum for these treatments.

"This is a regulatory space where they've been vague and very fuzzy — and businesses flock to gaps like that. They head straight for those regulatory gaps and they exploit them as long as they can."


To read the entire Second Opinion newsletter every Saturday morning, subscribe.

About the Author

Kelly Crowe

Medical science

Kelly Crowe is a science correspondent for CBC News. She joined CBC in 1991, and has spent 25 years reporting on a wide range of national news and current affairs, with a particular interest in science and medicine.

now